Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies

European Journal of Dermatology

Volumn 17, Issue 6, 2007, Pages 530-533

  Cozzani, Emanuele ^a   Christana, Konstantina ^a   Mastrogiacomo, Alessandro ^b   Rampini, Paolo ^a   Drosera, Massimo ^a   Casu, Massimo ^a   Murialdo, Giovanni ^a   Parodi, Aurora ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Autoantibodies; Desmoglein 1; Desmoglein 3; Pemphigus vegetans; Periplakin

Indexed keywords

AZATHIOPRINE; DESMOGLEIN; PERIPLAKIN; PREDNISONE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LABORATORY TEST; LYMPHOPROLIFERATIVE DISEASE; MALE; PEMPHIGUS; SKIN BIOPSY; SKIN EXAMINATION; SOLID TUMOR;

AGED; AUTOANTIBODIES; DESMOGLEIN 1; DESMOGLEIN 3; FEMALE; HUMANS; IMMUNOLOGIC TESTS; MALE; PEMPHIGUS; PLAKINS; SKIN;

EID: 36749036667     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2007.0270     Document Type: Article

References (21)

1. Ohata Y, Komiya H, Kawahara Y, Watanabe K, Nishikawa T, Hashimoto T. A case of Newmann type pemphigus vegetans showing reactivity with the 130 kD pemphigus vulgaris antigen. Acta Derm Venereol 1996; 76: 169-70.
2. Nanza A, Bazek A. Formes cliniques de pyodermites vegetantes. Ann Dermatol Syph 1937; 8: 609-23.
3. Hallopeau H. Pyodermite vegetante, ihre beziehungen zur dermatitis herpetiformis und dem pemphigus vegetans. Arch Dermatol Syph 1898; 43: 289-306.
4. Hashimoto T, Amagai M, Watanabe K, Chorzelski TP, Bhogal BS, Black MM, Stevens HP, Boorsma DM, Korman NJ, Gamou S, Shimizui N, Nishikawa T. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995; 104: 829-34.
5. Joly P, Richard C, Gilbert D, Courville P, Chosidow O, Roujeau JC, Beylot-Barry M. D'incan M, Martel P, Lauret P, Tron F. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000; 43: 619-26.
6. Parodi A, Stanley JR, Ciaccio M, Rebora A. Epidermal antigens in pemphigus vegetans. Report of a case. Br J Dermatol 1988; 119: 799-802.
7. Morizane S, Yamamoro T, Hisamatsu Y, Tsuji K, Oono T, Hashimoto T, Iwatsuki K. Pemphigus vegetans with IgG and IgA antidesmoglein 3 antibodies. Br J Dermatol 2005; 153: 1236-7.
8. Hashimoto K, Hashimoto T, Higashiyama M, Nishikawa T, Garrod DR, Yoshikawa K. Detection or anti-desmocollins I and II autoantibodies in two cases of Hallopeau type pemphigus vegetans by immunoblot analysis. J Dermatol Sci 1994; 7: 100-6.
9. Jiao D, Bystryn JC. Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus. J Am Acad Dermatol 1997; 37: 211.
10. Cozzani E, Kanitakis J, Nicolas JF, Schmitt D, Thivolet J. Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus. Arch Dermatol Res 1994; 286: 295-9.
11. Leung CL, Green KJ, Liem RK. Plakins: a family of versatile cytolinker proteins. Trends Cell Biol 2002; 12: 37-45.
12. Nagata Y, Karashima T, Watt FM, Salmhofer W, Kanzaki T, Hashimoto T. Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the C-terminal homologous domain of periplakin. J Invest Dermatol 2001; 116: 556-63.
13. Kazerounian S, Mahoney MG, Uitto J, Aho S. Envoplakin and periplakin, the paraneoplastic pemphigus antigens, are also recognized by pemphigus foliaceus autoantibodies. J Invest Dermatol 2000; 115: 505-7.
14. Park GT, Quan G, Lee JB. Sera from patients with toxic epidermal necrolysis contain autoantibodies to periplakin. Br J Dermatol 2006; 155: 337-43.
15. Kim SC, Chung YL, Kim J, Cho NJ, Amagai M. Pemphigus vulgaris with autoantibodies to desmoplakin. Br J Dermatol 2001; 145: 838-40.
16. Jiao D, Bystryn JC. Antibodies to desmoplakin in a patient with pemphigus foliaceous. J Eur Acad Dermatol Venereol 1998; 11: 169-72.
17. Mimouni D, Foedinger D, Kouba DJ, Orlow SJ, Rappersberger K, Sciubba JJ, Nikolskaia OV, Cohen BA, Anhalt GJ, Nousari CH. Mucosal dominant pemphigus vulgaris with antidesmoplakin autoantibodies. J Am Acad Dermatol 2004; 51: 62-7.
18. Hashimoto T, Watanabe K, Ishiko A, Shimizu H, Hanyaku H, Kimura S, Nishikawa T. A case of bullous pemphigoid with antidesmoplakin autoantibodies. Br J Dermatol 1994; 131: 694-9.
19. Okura M, Tatsuno Y, Sato M, Hashizume S, Kubota Y, Matumura K, Hashimoto T, Mizoguchi M. Vesicular pemphigoid with antidesmoplakin autoantibodies. Br J Dermatol 1997; 136: 794-6.
20. Foedinger D, Sterniczky B, Elbe A, Anhalt G, Wolff K, Rappersberger K. Autoantibodies against desmoplakin I and II define a subset of patients with erythema multiforme major. J Invest Dermatol 1996; 106: 1012-6.
21. Cozzani E, Dal Bello MG, Mastrogiacomo A, Drosera M, Parodi A. Antidesmoplakin antibodies in pemphigus vulgaris. Br J Dermatol 2006; 154: 624-8.